Eubiotics Market

The global eubiotics market is projected to grow from USD 4.84 billion in 2016 and reach USD 7.48 billion by 2022, at a CAGR of 7.51% from 2016 to 2022. Consumption of eubiotics-based feed provides basic nutritional components as well as health and medicinal benefits to livestock, such as preclusion and cure of diseases. Eubiotics enhances microflora in the gut of the host and increasing lactose tolerance level, which helps in healthy growth of the livestock.

Increasing awareness about feed quality and safety to drive the global eubiotics market

The growth of the eubiotics market is driven by the rising customer awareness towards superior quality feed grades, which are nutritive and have an accurate composition of ingredients to maintain the balance during consumption. Manufacturers are focusing on maintaining a balance in the ingredients used in the production of eubiotics to optimize nutrient absorption. In addition, the imposition of bans on antibiotics in North America and Europe, rise in prices of natural feed grades, and the use of feed enzymes for cost reduction of feed grades further contribute to the growth of the market. The high-growth potential in emerging markets provides new growth opportunities to the market players.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132956187

The following are the major objectives of the study.

• To understand the eubiotics market by identifying its various subsegments
• To define, segment, and project the size of the eubiotics market with respect to type, livestock, form, and region
• To provide detailed information regarding the crucial factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze the micromarkets with respect to individual growth trends, future prospects, and contribution to the total market
• To project the size of the market, in terms of value, in the four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
• To analyze opportunities in the eubiotics market for stakeholders and provide the details of the competitive landscape for key market leaders

The poultry segment projected to be the fastest-growing market during the forecast period

The poultry segment is projected to be the fastest-growing market from 2016 to 2022. The role of eubiotics in poultry includes altering the metabolism by enhancing digestive enzyme activity, maintaining normal intestinal microflora, and reducing bacterial enzyme activity and ammonia production. They improve feed intake and digestion, neutralize enterotoxins, and stimulate the immune system. The Asia-Pacific market for eubiotics in the poultry segment accounted for the largest share in 2015.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=132956187

Significant growth for eubiotics in animal feed observed in the European region

Eubiotics have tremendous market opportunities in the animal feed industry around the world. The animal feed industry in the European and Asia-Pacific regions is significantly influenced by the demand for animal feed additives, increase in concerns toward disease outbreak in livestock, and rise in demand for milk and meat products. The demand for eubiotics-based products in animal feed is continuously increasing in the Asia-Pacific region. Increase in awareness about the health benefits derived from eubiotics is also the prime factor driving the demand for eubiotics-based animal feed in this region.

This report includes a study of marketing and development strategies, along with the product portfolio of leading companies. It includes the profiles of leading companies such as Cargill (U.S.), BASF SE (Germany), E. I. du Pont de Nemours and Company (U.S.), Koninklijke DSM N. V. (Netherlands), Chr. Hansen A/S (Denmark), Novozymes (Denmark), Calpis Co., Ltd. (Japan), Lesaffre Group (France), Kemin Industries, Inc. (U.S.), Lallemand Inc. (Canada), ADDCON (Germany), Behn Meyer (Malaysia), Novus International Inc. (U.S.), and Advanced BioNutrition Corporation (U.S.)